rs372436251

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 1P and 10B. PP2BP4_ModerateBS1BS2

The NM_002700.3(POU4F3):​c.490C>A​(p.Pro164Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,457,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P164S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

POU4F3
NM_002700.3 missense

Scores

7
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.14

Publications

0 publications found
Variant links:
Genes affected
POU4F3 (HGNC:9220): (POU class 4 homeobox 3) This gene encodes a member of the POU-domain family of transcription factors. POU-domain proteins have been observed to play important roles in control of cell identity in several systems. This protein is found in the retina and may play a role in determining or maintaining the identities of a small subset of visual system neurons. Defects in this gene are the cause of non-syndromic sensorineural deafness autosomal dominant type 15. [provided by RefSeq, Mar 2009]
POU4F3 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 15
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 11 curated pathogenic missense variants (we use a threshold of 10). The gene has 1 curated benign missense variants. Trascript score misZ: 0.60352 (below the threshold of 3.09). GenCC associations: The gene is linked to autosomal dominant nonsyndromic hearing loss 15, autosomal dominant nonsyndromic hearing loss, nonsyndromic genetic hearing loss.
BP4
Computational evidence support a benign effect (MetaRNN=0.18767709).
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00000412 (6/1457398) while in subpopulation SAS AF = 0.0000696 (6/86256). AF 95% confidence interval is 0.00003. There are 0 homozygotes in GnomAdExome4. There are 5 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU4F3NM_002700.3 linkc.490C>A p.Pro164Thr missense_variant Exon 2 of 2 ENST00000646991.2 NP_002691.1 Q15319
RBM27-POU4F3NM_001414499.1 linkc.*359C>A 3_prime_UTR_variant Exon 20 of 20 NP_001401428.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU4F3ENST00000646991.2 linkc.490C>A p.Pro164Thr missense_variant Exon 2 of 2 NM_002700.3 ENSP00000495718.1 Q15319
ENSG00000250025ENST00000515598.1 linkn.404-32641G>T intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000810
AC:
2
AN:
247048
AF XY:
0.00000746
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000412
AC:
6
AN:
1457398
Hom.:
0
Cov.:
31
AF XY:
0.00000689
AC XY:
5
AN XY:
725304
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49092
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111910
Other (OTH)
AF:
0.00
AC:
0
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Uncertain
0.063
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.030
Eigen_PC
Benign
0.098
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.76
.;T
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.19
T;T
MetaSVM
Uncertain
-0.12
T
MutationAssessor
Uncertain
2.0
M;M
PhyloP100
2.1
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-1.6
.;N
REVEL
Uncertain
0.51
Sift
Benign
0.078
.;T
Sift4G
Benign
0.077
.;T
Polyphen
0.083
B;B
Vest4
0.60
MutPred
0.22
Gain of glycosylation at P164 (P = 0.0645);Gain of glycosylation at P164 (P = 0.0645);
MVP
0.91
MPC
0.79
ClinPred
0.21
T
GERP RS
4.5
Varity_R
0.21
gMVP
0.63
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372436251; hg19: chr5-145719480; API